• 1. Catalytically atroposelective ring-opening of configurationally labile compounds to access axially chiral biaryls
  Guanjie Wang,Jie Huang,Junmin Zhang,Zhenqian Fu Org. Chem. Front. 2022 9 4507
• 2. Fluorine & chirality: how to create a nonracemic stereogenic carbon–fluorine centre?
  Dominique Cahard,Xiuhua Xu,Samuel Couve-Bonnaire,Xavier Pannecoucke Chem. Soc. Rev. 2010 39 558
• 3. An efficient Cu(ii)-bis(oxazoline)-based polymer immobilised ionic liquid phase catalyst for asymmetric carbon–carbon bond formation
  Simon Doherty,Julian G. Knight,Jack R. Ellison,Peter Goodrich,Leanne Hall,Christopher Hardacre,Mark J. Muldoon,Soomin Park,Ana Ribeiro,Carlos Alberto Nieto de Castro,Maria José Louren?o,Paul Davey Green Chem. 2014 16 1470
• 4. Ni(ii)-Catalyzed enantioselective Mukaiyama–Mannich reaction between silyl enol ethers and cyclic N-sulfonyl α-ketiminoesters
  Lei Xie,Hongli Ma,Jiaqi Li,Yuan Yu,Zhaohai Qin,Bin Fu Org. Chem. Front. 2017 4 1858
• 5. Influence of counterions on the structure of bis(oxazoline)copper(ii) complexes; an EPR and ENDOR investigation
  Mari Elena Owen,Emma Carter,Graham J. Hutchings,Benjamin D. Ward,Damien M. Murphy Dalton Trans. 2012 41 11085

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzene and substituted derivatives
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives
• Catalysts and Inorganic Chemicals Catalysts

Introduction to (S,S)-2,2'-Isopropylidenebis(4-phenyl-2-oxazoline) and Its CAS No. 131457-46-0

(S,S)-2,2'-Isopropylidenebis(4-phenyl-2-oxazoline) is a highly specialized organic compound with the CAS number 131457-46-0. This compound has garnered significant attention in the field of chemical and pharmaceutical research due to its unique structural properties and potential applications. As a chiral ligand, it plays a crucial role in asymmetric synthesis, enabling the production of enantiomerically pure compounds which are essential in the development of pharmaceuticals and fine chemicals.

The molecular structure of (S,S)-2,2'-Isopropylidenebis(4-phenyl-2-oxazoline) consists of two oxazoline units linked by an isopropylidene group, with each oxazoline ring substituted with a phenyl group at the 4-position. This configuration imparts exceptional steric and electronic properties, making it an ideal candidate for catalytic applications. The presence of two stereocenters in the molecule ensures its chiral nature, which is critical for achieving high enantioselectivity in chemical reactions.

In recent years, there has been a surge in research focusing on the development of novel chiral ligands for asymmetric catalysis. Among these, (S,S)-2,2'-Isopropylidenebis(4-phenyl-2-oxazoline) has emerged as a standout compound due to its remarkable performance in various catalytic systems. For instance, it has been widely used in transition metal-catalyzed reactions such as hydrogenation, epoxidation, and cross-coupling reactions. These reactions are pivotal in synthesizing complex organic molecules, particularly in the pharmaceutical industry.

One of the most notable applications of (S,S)-2,2'-Isopropylidenebis(4-phenyl-2-oxazoline) is in the asymmetric hydrogenation of prochiral alkenes. This process is crucial for producing enantiomerically pure drugs that exhibit higher efficacy and fewer side effects compared to their racemic counterparts. Recent studies have demonstrated that this ligand can achieve outstanding enantioselectivity in hydrogenation reactions catalyzed by metals such as rhodium and palladium. The high turnover numbers and excellent catalyst turnover frequencies observed in these reactions highlight the compound's efficiency and robustness.

The synthesis of (S,S)-2,2'-Isopropylidenebis(4-phenyl-2-oxazoline) is another area of intense interest. Researchers have developed multiple synthetic routes to produce this compound with high enantiomeric purity. One such method involves the reaction of 4-bromophenol with sarcosine under acidic conditions, followed by cyclization and subsequent purification steps. These synthetic strategies have been optimized to ensure scalability and cost-effectiveness, making it feasible for industrial applications.

The pharmaceutical industry has been particularly keen on exploring the potential of (S,S)-2,2'-Isopropylidenebis(4-phenyl-2-oxazoline) due to its ability to facilitate the synthesis of biologically active molecules. For example, it has been employed in the preparation of nonsteroidal anti-inflammatory drugs (NSAIDs) and other therapeutic agents. The ability to produce these drugs with high enantiomeric purity has significantly enhanced their pharmacological properties. Additionally, the compound's stability under various reaction conditions makes it a reliable choice for large-scale synthesis.

Recent advancements in computational chemistry have also contributed to a deeper understanding of the mechanistic aspects of reactions involving (S,S)-2,2'-Isopropylidenebis(4-phenyl-2-oxazoline). Molecular modeling studies have revealed insights into how this ligand interacts with transition metals and substrates, providing a foundation for further optimization of catalytic systems. These computational approaches are complemented by experimental investigations, which have collectively enhanced our knowledge of this compound's reactivity and selectivity.

The environmental impact of using chiral ligands like (S,S)-2,2'-Isopropylidenebis(4-phenyl-2-oxazoline) is another critical consideration. Efforts have been made to develop green chemistry principles that minimize waste and reduce energy consumption during synthesis. For instance, solvent-free reactions and catalytic cycles that require less harsh conditions have been explored. These sustainable practices align with global efforts to promote environmentally friendly chemical processes.

In conclusion, (S,S)-S,S- isopropylidenebis(4- phenyl- Oxazole) (CAS No._131457460) represents a significant advancement in chiral catalysis with diverse applications across pharmaceuticals and fine chemicals industries. Its unique structural features enable high enantioselectivity in various catalytic reactions while adhering to sustainable chemical practices.

• 1428328-51-1(1,3-Bis[4-(tert-butyl)phenyl]-2,2-Bis[(S)-4-phenyl-4,5-dihydro-2-oxazolyl]propane)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)